Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease.
about
Association between Genetic Polymorphisms and Response to Anti-TNFs in Patients with Inflammatory Bowel DiseaseSystematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseasesAnti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasomeThe polymorphisms of tumor necrosis factor-induced protein 3 gene may contribute to the susceptibility of chronic primary immune thrombocytopenia in Chinese population.A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine.Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategiesPatterns of airway involvement in inflammatory bowel diseasesPlacental genome and maternal-placental genetic interactions: a genome-wide and candidate gene association study of placental abruptionPolymorphisms in NFKB1 and TLR4 and interaction with dietary and life style factors in relation to colorectal cancer in a Danish prospective case-cohort studyIn-silico analysis of inflammatory bowel disease (IBD) GWAS loci to novel connections.Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases.Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort.Polymorphisms in Toll-like receptor genes are associated with vitiligoTNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD.Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.IL1B-CGTC haplotype is associated with colorectal cancer in admixed individuals with increased African ancestry.Polymorphisms in genes TLR1, 2 and 4 are associated with differential cytokine and chemokine serum production in patients with leprosy.Potential Impact of Diet on Treatment Effect from Anti-TNF Drugs in Inflammatory Bowel Disease.Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis.Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy.Pharmacogenetics of inflammatory bowel disease: a focus on Crohn's disease.Single nucleotide polymorphisms of TNFAIP3 are associated with systemic lupus erythematosus in Han Chinese population.Colitis Is Effectively Ameliorated by (±)-8-Acetonyl-dihydrocoptisine via the XBP1-NF-κB Pathway.The role of polymorphonuclear neutrophils during HIV-1 infection.Calpain-2 Inhibitor Therapy Reduces Murine Colitis and Colitis-associated Cancer.Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis.Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.The polymorphism rs763780 in the IL-17F gene is associated with response to biological drugs in patients with psoriasis.Tumor necrosis factor α-induced protein 3 (A20) is dysregulated in pediatric Crohn disease.Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel DiseasesGenetically determined high activities of the TNF-alpha, IL23/IL17, and NFkB pathways were associated with increased risk of ankylosing spondylitis
P2860
Q26767247-C0F1BE91-7769-4150-B43C-8559AD88158EQ28072105-0FE9856E-E058-4889-BEB3-CE71D269C6DDQ28540052-D6969BEC-C076-4E6F-9B83-BDF0C0047579Q33421426-5FDC22CD-64C1-4E9A-A587-CC17A70A374DQ33749513-8AB858FF-A05D-44A0-8508-0CF98A90DB69Q33758469-E18EF5EA-145A-41E7-B7AB-617AAD801E1AQ34508886-27AFFEFF-E36B-4190-B420-0E1097A6E1DDQ34790582-606F218E-6FF3-4255-91BD-17F1AC1F9750Q35112128-7354E476-CBBD-4B4E-846D-EAAEE5E0BB96Q35191804-F79124C2-FCAA-4A59-B225-A2DE180801D2Q35614331-8B58DEC8-09D8-4D3E-B13C-8B2F3C172D5DQ35876578-7ADDB466-B606-4C68-93D3-7296BCCBD259Q36039023-DE1C3BD3-1B28-4A21-A370-7F962A54517EQ36453770-0BDFF387-DE8E-41E0-B860-7C97BC0A8AD3Q37411301-7178881C-0138-46E7-B659-61E4EEAB9699Q37623689-E4BEF91F-716D-40D6-A1FC-78FF50458F5CQ37705724-BADAC5FC-4EC8-4C88-95E2-F58F3B7C2CC0Q37729846-DB17D14C-5903-45B1-A9D7-B41A3425F814Q38684354-2028948E-6EB4-414A-97B2-6F871963FCB9Q38728689-B299EC6A-7297-4296-81BD-F12182F799DAQ38990031-4F9C6925-FDBA-4128-83ED-CFAA8D347583Q39420665-8131FE34-1FE9-4CDF-A643-A4FE30CE29B0Q40022964-B24677D4-1E4E-4346-8B13-032F4ABB4778Q41455884-688595C0-DB86-4FAD-A363-F04EDAFE7FB9Q41923884-AE2F6A64-6148-4414-B895-C16A0EBABFA4Q42588907-8A0901BB-79CC-45C9-B740-0FE3C94FB33EQ47640799-A8C5202D-6C6A-42BE-A4AD-B022BA6A217BQ48136341-12A4C4B4-BDD6-41C1-8264-8288A741D742Q50436409-845C3247-81EA-458F-9C70-FC33F7033B36Q54976742-735AD080-60C3-4309-BD72-BB31ACF18C0DQ58698145-12C0EA76-608D-4A43-966F-EE3B39553BEEQ58747224-92E7A5AB-7EDB-40A9-9F4D-481133E20B66
P2860
Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Associations between functiona ...... th inflammatory bowel disease.
@en
Associations between functiona ...... th inflammatory bowel disease.
@nl
type
label
Associations between functiona ...... th inflammatory bowel disease.
@en
Associations between functiona ...... th inflammatory bowel disease.
@nl
prefLabel
Associations between functiona ...... th inflammatory bowel disease.
@en
Associations between functiona ...... th inflammatory bowel disease.
@nl
P2093
P2860
P50
P356
P1476
Associations between functiona ...... th inflammatory bowel disease.
@en
P2093
B K Rasmussen
H J Hoffmann
J B Brodersen
J Galsgaard
M Frydenberg
M K Thomsen
N Pedersen
P S Andersen
P2860
P2888
P304
P356
10.1038/TPJ.2014.19
P577
2014-04-29T00:00:00Z